Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safety TONI studie: slimme vernevelaar voor tobramycine bij kinderen met cystic fibrosis: farmacokinetiek en veiligheid

Trial Profile

Tobramycin nebulisation with I-neb (TONI) study in children with cystic fibrosis: pharmacokinetics and safety TONI studie: slimme vernevelaar voor tobramycine bij kinderen met cystic fibrosis: farmacokinetiek en veiligheid

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Dec 2013

At a glance

  • Drugs Tobramycin (Primary)
  • Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
  • Focus Pharmacokinetics
  • Acronyms TONI
  • Most Recent Events

    • 06 Nov 2013 New source identified and integrated (Netherlands Trial Register, NTR4216).
    • 23 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top